Breaking News
April 18, 2019 - New gene therapy cures babies with fatal ‘Bubble Boy’ disease
April 18, 2019 - No female mice? Scientists may still approve NIH grant
April 18, 2019 - What needs to be said about mental health in medicine
April 18, 2019 - Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
April 18, 2019 - Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
April 18, 2019 - Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
April 18, 2019 - Adhesive gel bonds to eye surface, could repair injuries without surgery
April 18, 2019 - The future of genomics: A podcast featuring Stanford geneticists
April 18, 2019 - As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
April 18, 2019 - APOE gene impacts sleep depending on gender and severity of Alzheimer’s
April 18, 2019 - PCORI’s newly approved awards focus on cancer pain and opioid use disorders
April 18, 2019 - New tool provides a standard way to measure effects of caring for survivors of TBI
April 18, 2019 - Smartphone use risks eye examination misdiagnosis
April 18, 2019 - How drug-resistant bugs grow in CF patients’ lungs
April 18, 2019 - Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
April 18, 2019 - Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
April 18, 2019 - Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
April 18, 2019 - New estimation method assesses natural variations in sex ratio at birth
April 18, 2019 - UTA scientist receives $1.17 million grant for cancer research
April 18, 2019 - Coagulation factor VIIa prevents bleeds in hemophilia animal models
April 18, 2019 - Researchers identify risk factors for severe infection after knee replacement
April 18, 2019 - Mass drug administration can offer community-level protection against malaria
April 18, 2019 - FDA’s added sugar label could have substantial health and cost-saving benefits
April 18, 2019 - Researchers identify cause of inherited metabolic disorder
April 18, 2019 - Single strip of white paint not sufficient to protect people who ride bikes
April 18, 2019 - Partner status influences link between sexual problems and self-efficacy in breast cancer survivors
April 18, 2019 - Colorectal Neoplasia Risk Up for Hodgkin Lymphoma Survivors
April 18, 2019 - Rigid spine muscular dystrophy – Genetics Home Reference
April 18, 2019 - Simple bile acid blood test could tell risk of stillbirth
April 18, 2019 - Center for Experimental Therapeutics aims to enable all steps of drug development | News Center
April 18, 2019 - Falling for telephone scams could be an early sign of dementia
April 18, 2019 - Researchers annotate key neuronal proteins in lamprey genome
April 18, 2019 - Study uncovers new biomarker for personalized cancer treatments
April 18, 2019 - Scientists enter research collaboration to find a cure for cancer
April 18, 2019 - Study to compare benefits of tai chi and mindfulness meditation on MS symptoms
April 18, 2019 - Gestational diabetes during pregnancy may increase risk of type 1 diabetes in children
April 18, 2019 - Is a New Remedy for Body Odor on the Horizon?
April 18, 2019 - Orthostatic hypotension – Genetics Home Reference
April 18, 2019 - Healing the heartbreak of stillbirth and newborn death
April 18, 2019 - Conference to highlight advances in human immune monitoring, bioinformatics | News Center
April 18, 2019 - Bacteria use viruses for self-recognition, study reveals
April 18, 2019 - New adhesive patch could help reduce post-heart attack muscle damage
April 18, 2019 - Researchers analyze the effects of dark play in a serious video game
April 18, 2019 - Scientists revive pig brain cells four hours after death
April 18, 2019 - Filial cannibalism and offspring abandonment may be forms of parental care
April 18, 2019 - Two proteins act in concert to maintain a healthy heart in mice, shows study
April 18, 2019 - Scientists create a functioning 3D printed heart
April 18, 2019 - Non-invasive vagus nerve stimulation improves disease symptoms in patients with rheumatoid arthritis
April 18, 2019 - Majority of men struggle to understand diagnosis and treatment of prostate cancer
April 18, 2019 - Researchers create new small molecules that may combat equine encephalitis viruses
April 18, 2019 - Animal-assisted therapy improves social behavior in patients with brain injuries
April 18, 2019 - Some viruses help protect harmful bacteria in CF patients | News Center
April 18, 2019 - Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients
April 18, 2019 - Men who have a resting heart rate of 75 bpm are twice as likely to die early
April 18, 2019 - Novel serum biomarkers to detect NAFLD-related fibrosis
April 18, 2019 - New study delves deeper into individual genomic differences than ever before
April 18, 2019 - Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients
April 18, 2019 - Emotional mirror neurons found in rats
April 18, 2019 - Sylvia Plevritis appointed chair of biomedical data science | News Center
April 18, 2019 - Cervical cancer subtype increasing in several subpopulations of women
April 18, 2019 - Yeast strain provides manufacturing boost to low-calorie sweetener derived from lactose
April 18, 2019 - One in five children and youth suffer from a mental disorder
April 18, 2019 - Improper inhaler use common in children with asthma
April 18, 2019 - C-Path and CDISC release global Therapeutic Area Standard for HIV research
April 18, 2019 - Integrating AI to analyze imaging data allows early recognition of heart disease
April 18, 2019 - Low-cost, high-speed algorithm may allow animal-free chemical toxicity testing
April 18, 2019 - HPV-negative cervical cancers are more aggressive with worse prognosis
April 18, 2019 - AI detects prostate cancer with same level of accuracy as experienced radiologists
April 18, 2019 - Study resolves sex differences in psychiatric illness risk
April 18, 2019 - Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD
April 18, 2019 - Cocktail of common antibiotics can fight resistant E. coli
April 18, 2019 - Persis Drell to give keynote address at medical school diploma ceremony | News Center
April 18, 2019 - EpicTogether: Remembering Our Why
April 18, 2019 - Study identifies novel loci contributing to asthma susceptibility in adults
April 18, 2019 - Gut bacteria and pregnancy
April 18, 2019 - New study finds that screening could help prevent rare types of cervical cancer
April 17, 2019 - Spatial orgnization of the genome can be altered using small molecules
April 17, 2019 - AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients
April 17, 2019 - Telemedicine tied to more antibiotics for kids, study finds
April 17, 2019 - Two medical students awarded 2019 Soros Fellowships for New Americans | News Center
Ohio researchers investigate racial disparity in non-alcoholic fatty liver disease

Ohio researchers investigate racial disparity in non-alcoholic fatty liver disease

image_pdfDownload PDFimage_print

Two top researchers at the Ohio University Heritage College of Osteopathic Medicine are working with two other institutions on a federally funded project to investigate why Hispanics are more prone to develop non-alcoholic fatty liver disease (NAFLD).

Project leader Sonia Michael Najjar, Ph.D., Osteopathic Heritage Foundation John J. Kopchick, Ph.D., Endowed Eminent Research Chair, said the cooperative venture will connect different and complementary lines of research “in a fascinating and a powerful way. I can’t stress enough how critical that is – it takes a village to move a project of this magnitude forward.” The research recently received nearly $3 million in funding from the National Institutes of Health (NIH).

Najjar will work with Heritage College colleague and co-principal investigator Vishwajeet Puri, Ph.D., the Osteopathic Heritage Foundation Ralph S. Licklider, D.O., Research Heritage Endowed Professor, and with investigators from the Charles R. Drew University of Medicine & Science in Los Angeles (led by Theodore C. Friedman, M.D., Ph.D.) and the University of Florida in Gainesville (led by Ali Zarrinpar, M.D., Ph.D.). The team at the Heritage College includes undergraduates, pre- and post-doctoral fellows, as well as senior research scientists Vishva Sharma, Ph.D. and Harrison Muturi, Ph.D. The investigative team also includes Janet E. Simon, Ph.D. from the College of Health Sciences and Professions (CHSP) to carry out statistical analysis.

Puri agreed that the researchers’ interests and expertise provide a strong foundation for these studies.

“This is a combination of primary care, basic and translational, and clinical research,” he said. “It’s a perfect combination of interdisciplinary research.” That’s one reason, he says, why the NIH is supportive of the project, and why Najjar and Puri consider themselves fortunate to have Friedman and Zarrinpar as collaborators.

NIH offers hefty support to attack a major health disparity

The National Institute on Minority Health and Health Disparities is funding the study at nearly $614,000 for the first year. With similar levels of funding for each year of the five-year project, the total award is for more than $2.9 million, making it one of the largest research grants the Heritage College has ever received.

“Drs. Najjar and Puri embody the spirit of discovery that is fueling medical advancement at the Heritage College,” said Ken Johnson, D.O., Heritage College executive dean and Ohio University chief medical affairs officer. “Their study of disparities in fatty liver disease – specifically, its higher incidence among people of Hispanic origin – directly correlates to our mission of improving the health and well-being of underserved populations. Tremendous gratitude is owed to the National Institutes of Health, whose support of this important research will yield improved treatment and prevention in years to come.”

Non-alcoholic fatty liver disease (NAFLD), including its more progressive form, non-alcoholic steatohepatitis (NASH), is the most common liver pathology in the United States. It occurs at higher rates in Hispanics than in non-Hispanic whites, to an extent that makes this ailment one of the nation’s most serious health disparities.

Previous research comparing a small sample of healthy livers from Hispanic and non-Hispanic liver donors uncovered genetic differences that have led scientists to believe that a significant amount of the increased susceptibility of Hispanics to NAFLD/NASH is due to variations in genes. “The genetic component is definitely significant,” Puri said. The new NIH-funded project will seek to identify in more detail the underlying molecular pathways in human cells, with the hope of eventually generating novel therapies to prevent onset of the disease.

Hispanics are also more prone than others to build up abdominal fat, and the researchers would like to find out if there is a causal connection between this factor and higher rates of NAFLD/NASH.

Connecting the research specialties of two top scientists

The study will link the main research areas of Najjar and Puri, who have pioneered major discoveries related to the proteins CEACAM1 and FSP27 (or CIDEC), respectively. CEACAM1 is a plasma membrane glycoprotein that Najjar has found to maintain normal metabolism by promoting insulin clearance and lowering fat production in the liver, while FSP27 is a fat-specific protein that Puri has found to play a role in positively regulating insulin sensitivity and fat metabolism in humans.

A working hypothesis is that lower FSP27 levels in the abdominal fat tissue of Hispanics lead to increased release of free fatty acids into the liver to be burned. Excessive fatty acid release markedly lowers CEACAM1 expression in the liver, a factor which Najjar has shown to cause fatty liver disease in mice. The severity of NAFLD correlates positively with the degree of the loss of CEACAM1 in the liver of obese and insulin-resistant patients.

In one part of the study, the researchers at Charles Drew University will analyze data on liver function from a national database from the Centers for Disease Control and Prevention to try to determine how big a role demographics, acculturation, physical activity, smoking, body composition, diet and genetics play in NAFLD/NASH.

In another part of the study, teams from the Heritage College and the University of Florida will investigate whether Hispanics show a lower level of FSP27 in their fat tissue and of CEACAM1 in their livers by comparison to non-Hispanic whites, and if this is underlined by higher levels of lipolysis leading to more fat deposition in the liver. Working on cell and tissue samples they will look for changes in liver function associated with changes in lipolysis.

Ultimately, the Heritage College researchers will seek to determine whether CEACAM1 levels are reduced in the livers of Hispanics compared to those of non-Hispanic whites, and whether this constitutes a missing molecular link between obesity, insulin resistance and NAFLD/NASH in Hispanics.

A commitment to stop ‘the new epidemic’

Najjar noted that she has determined in past research that mice that had been genetically modified to express more CEACAM1 in their livers do not develop NAFLD/NASH even on a high-fat diet.

“You can give the mice as much high-fat as you want, and they are totally protected from developing NAFLD/NASH,” she said. “Moreover, introducing CEACAM1 to the liver of mice after high-fat is initiated reverses all metabolic abnormalities caused by high-fat feeding.” This raises the possibility that a drug intervention promoting higher CEACAM1 levels might be a treatment for the disease in humans.

Puri added that future research will be made easier as the Heritage College research team uses what it learns from the new NIH-funded study to develop genetically modified mice lines that can stand in for human research subjects.

“We are generating ‘humanized’ mouse models for future research,” he said. “And we hope this research will help us identify novel molecular factors that could be used as targets in therapeutics for fatty liver disease.”

In addition to being a sterling example of collaborative, multi-pronged research, Najjar said the new study is going after a disease that’s a significant and growing global health problem.

“Fatty liver disease is the new epidemic, and we are not ignoring it,” she said. “It is my scientific mission to solve this issue and find a drug that induces CEACAM1 to curb this disease.”

Source:

https://www.ohio.edu/ucm/media/news-story.cfm?newsItem=8948C652-5056-A874-1D1BDB4E3B497582

Tagged with:

About author

Related Articles